Literature DB >> 19396802

Retinal pigment epithelial tumor in a young Asian female.

Melis Palamar1, Carol L Shields, Brian P Marr, Ralph C Eagle, Jerry A Shields.   

Abstract

PURPOSE: To report a case of low-grade adenocarcinoma of the retinal pigment epithelium (RPE) in a young Asian woman.
METHODS: Interventional case report with histopathologic correlation.
RESULTS: A 28-year-old Asian woman with a year-long history of floaters presented with a dark pigmented lesion in the right eye. Partial lamellar sclerouvectomy was performed and histopathology revealed a retina pigment epithelial neoplasm consistent with a low-grade adenocarcinoma. The patient responded well to the surgery with no complications.
CONCLUSIONS: Neoplasms of RPE are rare but must be differentiated from choroidal melanoma, as they do not tend to metastasize. Local resection can be a good option for peripheral RPE tumors.

Entities:  

Mesh:

Year:  2009        PMID: 19396802     DOI: 10.1177/112067210901900329

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  4 in total

1.  Treatment Outcome of Acquired Retinal Pigment Epithelial Tumors with Rhuthenium-106 Plaque Radiotherapy: Experience on Two Cases.

Authors:  Masood Naseripour; Ahad Sedaghat; Parya Abdolalizadeh; Ehsan Azizi
Journal:  J Curr Ophthalmol       Date:  2020-07-04

Review 2.  Retinal Pigment Epithelium Adenoma and Adenocarcinoma: A Review.

Authors:  Janani Sreenivasan; Pukhraj Rishi; Kalpita Das; Subramanian Krishnakumar; Jyotirmay Biswas
Journal:  Ocul Oncol Pathol       Date:  2020-12-22

Review 3.  Partial lamellar sclerouvectomy surgery for anteriorly located uveal tumour resection: a 20-year experience.

Authors:  Ibadulla Mirzayev; Ahmet Kaan Gündüz; Aylin Okçu Heper
Journal:  Eye (Lond)       Date:  2021-05-03       Impact factor: 4.456

4.  A Case of Adenocarcinoma of the Retinal Pigment Epithelium: An Immunohistochemical and Electron Microscopic Study.

Authors:  Hidetsugu Mori; Kanji Takahashi
Journal:  Ocul Oncol Pathol       Date:  2017-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.